FDA — authorised 18 January 2013
- Application: NDA203595
- Marketing authorisation holder: BRAINTREE LABS
- Local brand name: SUCLEAR
- Indication: SOLUTION — ORAL
- Status: approved
🇺🇸 SUCLEAR® in United States
FDA authorised SUCLEAR® on 18 January 2013
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is SUCLEAR® approved in United States?
Yes. FDA authorised it on 18 January 2013.
Who is the marketing authorisation holder for SUCLEAR® in United States?
BRAINTREE LABS holds the US marketing authorisation.